Quick Answer
TENAX THERAPEUTICS, INC. reported Earnings Per Share Diluted of $1.34 (loss) per share for the year ending 2025.
- TENAX THERAPEUTICS, INC. showed a decrease of -16.5% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from TENAX THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2011 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2010: $0.13 (loss) per share | Q4 2010: $0.09 (loss) per share | Q1 2011: $0.11 (loss) per share | Q3 2011: $0.33 (loss) per share | Q4 2011: $0.29 (loss) per share | Q1 2012: $0.39 (loss) per share | Q3 2012: $4.30 (loss) per share | Q4 2012: $2.63 (loss) per share | Q1 2013: $2.78 (loss) per share | Q3 2013: $3.36 (loss) per share | Q4 2013: $1.25 (loss) per share | Q1 2014: $0.44 (loss) per share | Q3 2014: $0.08 (loss) per share | Q4 2014: $0.14 (loss) per share | Q1 2015: $0.10 (loss) per share | Q1 2024: $3.12 (loss) per share | Q2 2024: $1.83 (loss) per share | Q3 2024: $0.19 (loss) per share | Q1 2025: $0.28 (loss) per share | Q2 2025: $0.27 (loss) per share | Q3 2025: $0.40 (loss) per share.
- Over the full 7 years of available data (2011 to 2025), TENAX THERAPEUTICS, INC.'s Earnings Per Share Diluted has declined by 197.8%.
- Historical annual values: Fiscal year 2025: $1.34 (loss) per share | Fiscal year 2024: $1.15 (loss) per share | Fiscal year 2023: $31.04 (loss) per share | Fiscal year 2014: $2.71 (loss) per share | Fiscal year 2013: $6.68 (loss) per share | Fiscal year 2012: $14.07 (loss) per share | Fiscal year 2011: $0.45 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: